Quantcast

Latest Peptides Stories

2010-11-02 18:30:00

BASKING RIDGE, N.J., Nov. 2, 2010 /PRNewswire/ -- Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced that Steven L.

2010-11-02 06:30:00

CRANBURY, N.J., Nov. 2, 2010 /PRNewswire/ -- Palatin Technologies, Inc.

cd9f292bc56f0abdbd2ad8e308dd53151
2010-10-30 12:45:46

Researchers led by Vanderbilt's Roger Cone, Ph.D., have discovered a new member of a gene family that has powerful influences on pigmentation and the regulation of body weight.

2010-10-26 09:17:00

BASKING RIDGE, N.J., Oct. 26 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that David J. Mazzo, PhD, President and CEO, will be presenting at the Oppenheimer 21st Annual Healthcare Conference.

2010-09-30 09:12:28

Researchers have identified biomarkers and protein signatures that are hallmarks of cancer at an early stage using aptamer-based proteomics array technology.

2010-09-28 20:51:00

Using a novel aptamer-based proteomics array technology, researchers and collaborators have identified biomarkers and protein signatures that are hallmarks of cancer at an early stage for two of the most aggressive and deadly forms of cancer — pancreatic and mesothelioma.

2010-09-16 09:17:00

BASKING RIDGE, N.J., Sept. 16 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that David J. Mazzo, PhD, President and CEO, will be presenting at the UBS Global Life Sciences Conference. Dr.

2010-09-09 09:17:00

BASKING RIDGE, N.J., Sept. 9 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that David J.

2010-08-05 15:29:38

Clinical trials from two international research teams have shown that icatibant, a new drug that blocks the action of an inflammatory protein known as bradykinin, is safe and effective in treating acute attacks of hereditary angioedema, a potentially life-threatening condition.